REVISIÓN
Una revisión de los avances en la terapéutica de la enfermedad de Alzheimer: estrategia frente a la proteína β-amiloide
Review of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein
J. Folcha,b, M. Ettchetoc, D. Petrovc, S. Abadc, I. Pedrósa, M. Marind, J. Olloquequie, A. Caminsb,c,d,
Autor para correspondencia
a Unitat de Bioquímica, Facultat de Medicina i Ciències de la Salut, Universitat Rovira i Virgili, Reus, Tarragona, España
b Centros de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, España
c Unitat de Farmacologia i Farmacognòsia, Facultat de Farmàcia, Institut de Biomedicina (IBUB), Universitat de Barcelona, Barcelona, España
d Centro de Biotecnología, Universidad Nacional de Loja, Loja, Ecuador
e Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile
Leído
30659
Vecesse ha leído el artículo
4610
Total PDF
26049
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 78 | 11 | 89 |
| 2025 11 | 517 | 62 | 579 |
| 2025 10 | 513 | 46 | 559 |
| 2025 9 | 471 | 49 | 520 |
| 2025 8 | 356 | 40 | 396 |
| 2025 7 | 388 | 18 | 406 |
| 2025 6 | 467 | 27 | 494 |
| 2025 5 | 744 | 43 | 787 |
| 2025 4 | 696 | 60 | 756 |
| 2025 3 | 766 | 36 | 802 |
| 2025 2 | 676 | 40 | 716 |
| 2025 1 | 515 | 41 | 556 |
| 2024 12 | 682 | 42 | 724 |
| 2024 11 | 1328 | 65 | 1393 |
| 2024 10 | 749 | 61 | 810 |
| 2024 9 | 725 | 51 | 776 |
| 2024 8 | 410 | 18 | 428 |
| 2024 7 | 470 | 32 | 502 |
| 2024 6 | 609 | 36 | 645 |
| 2024 5 | 561 | 50 | 611 |
| 2024 4 | 516 | 55 | 571 |
| 2024 3 | 415 | 38 | 453 |
| 2024 2 | 341 | 41 | 382 |
| 2024 1 | 433 | 35 | 468 |
| 2023 12 | 410 | 42 | 452 |
| 2023 11 | 595 | 85 | 680 |
| 2023 10 | 673 | 29 | 702 |
| 2023 9 | 373 | 39 | 412 |
| 2023 8 | 333 | 16 | 349 |
| 2023 7 | 431 | 26 | 457 |
| 2023 6 | 463 | 52 | 515 |
| 2023 5 | 627 | 36 | 663 |
| 2023 4 | 464 | 31 | 495 |
| 2023 3 | 300 | 38 | 338 |
| 2023 2 | 231 | 19 | 250 |
| 2022 1 | 215 | 19 | 234 |
| 2022 12 | 225 | 33 | 258 |
| 2022 11 | 352 | 48 | 400 |
| 2022 10 | 346 | 68 | 414 |
| 2022 9 | 224 | 26 | 250 |
| 2022 8 | 176 | 18 | 194 |
| 2022 7 | 109 | 29 | 138 |
| 2022 6 | 136 | 32 | 168 |
| 2022 5 | 156 | 59 | 215 |
| 2022 4 | 129 | 27 | 156 |
| 2022 3 | 150 | 44 | 194 |
| 2022 2 | 121 | 28 | 149 |
| 2021 1 | 160 | 18 | 178 |
| 2021 12 | 137 | 30 | 167 |
| 2021 11 | 127 | 32 | 159 |
| 2021 10 | 191 | 68 | 259 |
| 2021 9 | 126 | 52 | 178 |
| 2021 8 | 146 | 18 | 164 |
| 2021 7 | 91 | 63 | 154 |
| 2021 6 | 211 | 62 | 273 |
| 2021 5 | 98 | 30 | 128 |
| 2021 4 | 296 | 137 | 433 |
| 2021 3 | 113 | 31 | 144 |
| 2021 2 | 101 | 26 | 127 |
| 2020 1 | 116 | 37 | 153 |
| 2020 12 | 83 | 26 | 109 |
| 2020 11 | 89 | 48 | 137 |
| 2020 10 | 48 | 16 | 64 |
| 2020 9 | 54 | 42 | 96 |
| 2020 8 | 55 | 17 | 72 |
| 2020 7 | 83 | 30 | 113 |
| 2020 6 | 85 | 21 | 106 |
| 2020 5 | 83 | 34 | 117 |
| 2020 4 | 77 | 30 | 107 |
| 2020 3 | 103 | 38 | 141 |
| 2020 2 | 97 | 33 | 130 |
| 2020 1 | 97 | 27 | 124 |
| 2019 12 | 90 | 28 | 118 |
| 2019 11 | 77 | 32 | 109 |
| 2019 10 | 81 | 34 | 115 |
| 2019 9 | 104 | 51 | 155 |
| 2019 8 | 63 | 46 | 109 |
| 2019 7 | 80 | 43 | 123 |
| 2019 6 | 157 | 37 | 194 |
| 2019 5 | 367 | 90 | 457 |
| 2019 4 | 160 | 96 | 256 |
| 2019 3 | 53 | 34 | 87 |
| 2019 2 | 64 | 40 | 104 |
| 2019 1 | 59 | 31 | 90 |
| 2018 12 | 66 | 24 | 90 |
| 2018 11 | 82 | 31 | 113 |
| 2018 10 | 78 | 53 | 131 |
| 2018 9 | 122 | 32 | 154 |
| 2018 8 | 48 | 36 | 84 |
| 2018 7 | 31 | 32 | 63 |
| 2018 6 | 25 | 27 | 52 |
| 2018 5 | 76 | 57 | 133 |
| 2018 4 | 37 | 36 | 73 |
| 2018 3 | 48 | 23 | 71 |
| 2018 2 | 149 | 31 | 180 |
| 2018 1 | 329 | 84 | 413 |
| 2017 12 | 14 | 22 | 36 |
| 2017 11 | 7 | 53 | 60 |
| 2017 10 | 9 | 28 | 37 |
| 2017 9 | 8 | 36 | 44 |
| 2017 8 | 6 | 33 | 39 |
| 2017 7 | 8 | 31 | 39 |
| 2017 6 | 1 | 47 | 48 |
| 2017 5 | 4 | 53 | 57 |
| 2017 4 | 2 | 54 | 56 |
| 2017 3 | 3 | 52 | 55 |
| 2017 2 | 1 | 45 | 46 |
| 2016 1 | 0 | 18 | 18 |
| 2016 12 | 1 | 33 | 34 |
| 2016 11 | 1 | 58 | 59 |
| 2016 10 | 3 | 40 | 43 |
| 2016 9 | 3 | 85 | 88 |
| 2016 8 | 0 | 65 | 65 |
| 2016 7 | 0 | 22 | 22 |
Mostrar todo
